News & Opinions Home
Market Place
Business Wire
Research and Markets: In 2009, the Vietnamese Market for Pharmaceuticals Is Estimated At US$750 Million, or US$9 Per Capita
Thursday June 4, 03:52 AM
Research and Markets(http://www.researchandmarkets.com/research/8b14c6/the_pharmaceutical)
has announced the addition of the "The
Pharmaceutical Market: Vietnam" report to their offering.
The biggest concern of the Vietnamese government is to make healthcare
universal and affordable to its populace, and this is particularly true
for pharmaceutical prices, which account for a significant portion of
annual expenditure on health, but as of 2009, the country is still
struggling to keep prices down, even though measures have been
introduced. While the government has focused on developing its domestic
production capability, which it now claims supplies just over 50% of the
market, it is now faced with another problem with no immediate solution
in sight; the rising price of raw materials, of which 90% are imported.
It has been recently reported that just three multinational distributors
- Zuellig Pharma, Mega Product and Diethelm - dominate the Vietnamese
pharmaceutical market through a complex network which enables them to
control the volume, thus prices, of drugs distributed in the country.
The government report criticised both foreign suppliers and local
importers for adopting strategies such as predatory pricing, boycotts,
exclusive deals and patent pooling to block competition from new
suppliers and importers.
Most healthcare expenditure is out-of-pocket in Vietnam, with national
health insurance only covering a small section of the population.
Private expenditure is estimated at around 67.6%. Health expenditure is
estimated at US$5.8 billion in 2009 and is projected to reach US$10.9
billion by 2014. Per capita health expenditure should reach US$116 from
an estimated US$66 in 2009. A new law was passed in November 2008, to
take effect in July 2009, which will make health insurance compulsory
for all citizens by 2014. Under the new law, there are three levels of
benefits under health insurance schemes, some will cover all or 100% of
expenses at nominated medical facilities, while others will cover 95%
and 80% of the expenses with the patient making up the rest.
In 2009, the Vietnamese market for pharmaceuticals is estimated at
US$750 million, or US$9 per capita. This is one of the lowest in the
world, yet an improvement on the estimated US$1.0 per capita figure a
decade or so ago. The overall market size is comparable to Singapore or
Bangladesh; in per capita terms, the market is similar to Pakistan and
India.
Espicom's in-depth pharmaceutical market reports are ideal for
executives wanting to understand the key drivers in pharmaceutical
markets and have access to a wealth of statistical data. Each report
opens with an outlook section that provides analysis of the market,
5-year market forecasts, national data projections, market outlook and
key developments such as regulation, pricing/reimbursement, intellectual
property, health facilities and government policy. The report also
provides extensive background information, population trends, health
status, health expenditure, organisation & administration, hospital
services, medical personnel, healthcare development, market access
information, trade data for raw materials and finished products and
essential industry contacts. Included with the report are 3 free
quarterly updated outlook reports, enabling you to keep up to date with
market developments for a year.
Key Topics Covered:
Executive Summary
Introduction
Current market size
Market Structure
Generic usage
Market projections & outlook
Imports
Domestic manufacturing
Multinational Manufacturing
Exports
Research & development
Pharmaceutical regulations
Pricing & reimbursement
Intellectual property
Distribution & retail
Demographics
Healthcare system
Health expenditure
Healthcare infrastructure
Healthcare personnel
Directory
Methodology & sources
Appendix: healthcare statistics
For more information visit http://www.researchandmarkets.com/research/8b14c6/the_pharmaceutical
Source: Espicom Business Intelligence Ltd
Contact:Laura WoodSenior Managerpress@researchandmarkets.comFax
from USA: 646-607-1907Fax from rest of the world: +353-1-481-1716
Next Article: Research and Markets: Direct Part Marking and Identification Systems, Volume 5C: Asia-Pacific
Previous article: Research and Markets: 2Q 2009 Report Finds That Taiwanese Smart Cellular Device Shipment Volume in the First Quarter of 2009 Was Not Strong
Top Headlines
Furukawa-Sky (TYO:5741) and Mitsui (TYO:8031) to Invest in Chinese Rolled Aluminum Firms
Friday October 9, 07:39 PM - Asia Business News
Tokyo, Japan, Oct 9, 2009 - (ABN Newswire) - Furukawa-Sky Aluminum Corp. (TYO:5741) will team up with Mitsui & Co. (TYO: .. Read More
Australia beats US in financial rankings
Friday October 9, 07:21 PM - AAP
Australia has moved into second position, behind the UK and ahead of the United States, in the World Economic Forum's ran .. Read More
Fairydown factory in Christchurch to close
Friday October 9, 06:44 PM - NZPA
The Australian-based owner of New Zealand brand Fairydown is shutting a factory in Christchurch and plans to have the goods m .. Read More
Calculators
Copyright © 2009 Yahoo! All rights reserved.
Yahoo!Xtra: A Yahoo!7/Telecom New Zealand Company.